Coenzyme Q10 Market
Coenzyme Q10 Market Size by Product Type (Ubiquinone Coenzyme Q10, Ubiquinol Coenzyme Q10), by Production Method (Coenzyme Q10 Production via Microbial Fermentation, Coenzyme Q10 Production via Chemical Synthesis) - Regional Outlook 2021-2031
Coenzyme Q10 Market Outlook
The coenzyme Q10 market is expected to reach US$ 1.3 Bn by the end of the forecast period 2021-2031. Revenues will more than double, with pharmaceutical applications emerging dominant and clocking a CAGR worth 7%. As of 2021, it is likely to reach US$ 600 Mn.
Coenzyme Q10 Consumption Analysis 2016-2020 in Comparison to Future Outlook 2021-2031
As per Fact.MR’s report, between 2016 and 2020, the sales of coenzyme Q10 surged at a CAGR of 6%, attributed to unceasing clinical studies aimed at determining the efficacy of the enzyme on potentially debilitating chronic conditions, including Parkinson’s disease.
Manufacturers of coenzyme Q10 are focusing on providing the same in various forms such as yogurts, powders and pills. This, in turn, is boosting the sales of coenzyme Q10. Further impetus was received during COVID-19, with several studies predicting that the pathobiochemical effects induced by the SARS-CoV-2 virus could lead to mitochondrial bioenergetics dysfunction, causing a shortage of CoQ10 in the body. Hence, patients would require its administration via the oral or intravenous routes.
In the future, prominent manufacturers are optimistic about coenzyme Q10 applications to treat a wide range of chronic and infectious ailments, prompting their incorporation across a range of nutraceuticals, dietary supplements and food formulations. Fact.MR expects this industry to flourish at a CAGR of 8% from 2021 to 2031.
Interested to Procure The Data
What Prominent Factors are Widening Growth Prospects for Coenzyme Q10?
The microbial fermentation method for coenzyme Q10 has gained more traction and adoption, which can be attributed to its effectiveness in synthesizing coenzyme Q10. With respect to the end-use industry, coenzyme Q10 is largely used in the nutraceuticals industry, owing to the high consumption and demand for nutraceutical supplements containing coenzyme Q10, which can be used as an efficient solution against various heart disorders.
Regulatory bodies, such as Food and Drug Association (FDA), have recognized coenzyme Q10 as Generally Recognized as Safe (GRAS), and are safely integrating it as a food additive. Coenzyme Q10 enhances the nutritional value of the food product. Apart from its usage as an energy enhancer in the human body, it is also largely used in cosmetic creams to tackle anti-aging, which is expected to drive the adoption of coenzyme Q10 and consequently push the growth of its market across the globe.
Moreover, its usage as a superior antioxidant has fuelled its adoption in various therapeutic applications that focus on minimizing the occurrence of several metabolic disorders including diabetes, cancer, and cardiovascular disorders. In addition to this, consumption of coenzyme Q10 supplements have facilitated positive outcomes, particularly in patients on statin medications. This factor is anticipated to be the driving force for the growth of the global market for coenzyme Q10 during the assessment period.
Among patients with cardiovascular diseases, substantial improvement is often seen when the heart cells’ ability to produce more ATP is sparked by the supplemental CoQ10.
How are Nutraceutical and Pharmaceutical Applications Spurring Sales?
Coenzyme Q10 is majorly used in pharmaceuticals, nutraceuticals, and cosmetics. Coenzyme Q10 enjoys high importance in the cosmetic industry, owing to its antioxidant properties.
It is the basic unit that is responsible for 95% of energy generation inside cells, and also plays a pivotal role in treating various diseases, such as CVD, secondary diabetes, lungs and kidney problems, and infertility. All these reasons are responsible for the growing demand for coenzyme Q10, which is expected to grow during the forecast period.
The nutraceuticals industry is capable of pushing the market ahead as increasing number of people are getting more concerned about their health and have started the consumption of supplemental pills, which is expected to boost the coenzyme Q10 market growth during the forecast period. The industry will grow at a rapid pace, majorly because of the presence of fitness freaks and health-concerned people.
People who are concerned about health are making use of supplements in the form of capsules, pills, and powders. Coenzymes are basic supplements that are naturally produced inside the body. When the level of coenzymes in Q10 decreases, it creates major problems. Thus, it leads to an increased consumption and is expected to have a high demand for coenzyme Q10 during the forecast period.
An Adaptive Approach to Modern-day Research Needs
How will Growing Incidence of Chronic Disorders across North America Affect Coenzyme Q10 Sales?
Countries such as the U.S. and Canada are witnessing an increase in the consumption of CoQ10 due to high incidences of diseases, such as high blood pressure, high cholesterol (especially when taking statin drugs), coronary heart diseases, heart arrhythmia diseases, atherosclerosis, and congestive heart failures.
CoQ10 helps protect heart and blood vessels from damaging effects of oxidative stress. Coenzyme Q10 is an immunity boosting enzyme that reduces the possibility of cancer. Furthermore, statin prescriptions have begun to treat patients with lower cholesterol levels in the country.
Increasing awareness regarding the negative impacts of statin will proliferate the demand for coenzyme Q10. According to the CoQ10 Association, around 16,000,000 individuals consume coenzyme Q10 daily. This is expected to support the growth of the coenzyme Q10 market in North America and generate a market share for more than 45% during the assessment period.
High Parkinson’s Disease Prevalence Accelerating Growth of Coenzymes Q10 in Asia?
According to Neurology Asia, global burden on Parkinson’s disease is expected to rise in the future. A majority of this burden is likely to be contributed by six of the most populous countries in Asia (India, China, Indonesia, Pakistan, Japan and Bangladesh). The incidence is likely to rise to 6.17 million by 2030.
Out of the aforementioned countries, 2/3rd of the prevalence rates are likely to be across China and India. Consequently, numerous clinical trials have been initiated in order to test the efficacy of coenzyme 10 across these countries, thus broadening growth prospects. As per Fact.MR, the region is expected to register more than 25% market share for coenzymes Q10 market in the assessment period.
While at the present moment there is no documented therapy to reduce the rate of progression of PD, several Phase II clinical trials have demonstrated that coenzyme Q10 in dosages of 300, 600 and 1200 mg/day was safe and well tolerated in individuals with early, untreated PD.
How are Pharmaceutical Applications Spurring Coenzyme Q10 Demand?
According to Fact.MR, pharmaceutical applications of coenzyme Q10 are anticipated to remain dominant. A CAGR of over 7% is anticipated for this segment across the forecast period.
Coenzyme Q10 is extensively used to address conditions affecting the heart, including congestive heart failure, angina, high blood pressure and cardiac arrest. In addition, they are also used to prevent migraine headaches, onset of Parkinson’s disease and other conditions.
Avail customized purchase options for your needs
Manufacturers of coenzyme Q10 are focusing on inducing the same in different formats and enriching the nutritional value.
- In January 2021, Kaneka Corporation launched a new product named Watashi no Chikara (My Energy Q10 Yogurt). The company is focusing on selling coenzyme Q10 through products which are liked by people and would add nutritional value to their everyday food.
|Market Size Value in 2021||USD 600 Million|
|Market Value Forecast in 2031||USD 1.3 Billion|
|Growth Rate||CAGR of 8% from 2021 to 2031|
|Historical Data Available for||2016-2020|
|Market Analysis||US$ Mn for Value & Kg for Volume|
|Key Regions Covered||
|Key Countries Covered||
|Key Segments Covered||
|Key Companies Profiled||
|Pricing||Available upon Request|
Key Segments Covered
- Ubiquinone Coenzyme Q10
- Ubiquinol Coenzyme Q10
- Coenzyme Q10 Production via Microbial Fermentation
- Coenzyme Q10 Production via Chemical Synthesis
End Use Industry
- Coenzyme Q10 for Pharmaceuticals
- Coenzyme Q10 for Nutraceuticals
- Coenzyme Q10 for Cosmetics
- Coenzyme Q10 for Other End Use Industries
- FAQs -
As of 2021, the market for coenzyme Q10 will reach US$ 600 Mn
The coenzyme Q10 market is expected to surpass a CAGR of 8% from 2021-2031.
The coenzyme Q10market is expected to reach nearly US$ 1.3 Bn by 2031
Extensive applications in pharmaceuticals and nutraceuticals will likely drive market growth
North America is anticipated to be the most lucrative market for coenzyme Q10, capturing 45% revenue
Coenzyme Q10 sales in Asia will account for 25% of the global market share
Prominent players operating in the global coenzyme Q10 market include Kaneka Corporation, Xiamen Kingdomway Group, Nisshin Seifun Group, Zhejiang Medicine Co. Ltd, and Kyowa Hakko U.S.A. Inc.
The pharmaceutical industry is expected to hold the highest share for sales, expanding at 7% CAGR
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
Chlor-Alkali Market is expected to garner a US$ 150 Billion revenue by 2032. Vinyl chloride polymers...
Siloxane Market research report Segmented By Type (Elastomer, Fluids, Resins, Gels), By Application ...
Hydrogen Leak Detectors to register a potential CAGR by 2031. Electro chemical hydrogen leak detecto...